PMV Pharmaceuticals (PMVP) vs Stablecoin Development (SDEV)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
PMV Pharmaceuticals (PMVP) has outperformed Stablecoin Development (SDEV) over the past year, gaining 10.3% versus a loss of 55.9%. Over five years, PMVP leads with a -93.7% price change compared with -99.9% for SDEV. PMV Pharmaceuticals is the larger company by market cap ($112.5 million vs $103.0 million), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | PMVP | SDEV |
|---|---|---|
| Share price | $1.49 | $1.99 |
| Market cap | $112.51M | $102.99M |
| 1-day change | -0.67% | -28.42% |
| YTD return | +20.00% | -90.14% |
| 1-year return | +10.29% | -55.87% |
| 5-year return | -93.74% | -99.92% |
| EPS (TTM) | $-1.42 | $-21.13 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $1.91 | $99.75 |
| 52-week low | $1.02 | $0.78 |
| Distance from 52-week high | -21.99% | -98.01% |
| Average volume | 655.83K | 11.42M |
| Shares outstanding | 75.51M | 51.75M |
| Employees | — | 2 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- PMVP has outperformed SDEV by 66.2 percentage points over the past year.
About Stablecoin Development
SDEV stock →Stablecoin Development Corporation engages in the accumulation and holding of digital assets for participation in blockchain-based networks. The company focuses on the accumulation, holding, and deployment of SKY, a protocol token of the decentralized Sky Protocol.
Health Care · Biotechnology: Pharmaceutical Preparations · 2 employees
PMVP vs SDEV FAQ
Which is bigger, PMV Pharmaceuticals or Stablecoin Development?
PMV Pharmaceuticals (PMVP) is larger, with a market capitalization of $112.51M compared with $102.99M for Stablecoin Development (SDEV).
Which stock has performed better over the past year, PMVP or SDEV?
PMVP returned +10.29% over the past 12 months, compared with -55.87% for SDEV (price return, excluding dividends). Past performance does not predict future results.
Are PMV Pharmaceuticals and Stablecoin Development in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.